
Neurologist

No OPD information available
AIDS Dementia Complex
HIV/AIDS
Alzheimer's Disease
Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
CACH Syndrome
Dementia
Encephalitis
Primary Lateral Sclerosis
Progressive Multifocal Leukoencephalopathy
COVID-19
Developmental Dysphasia Familial
Heart Tumor
Huntington Disease
Increased Intracranial Pressure
Kaposi Sarcoma
Liver Failure
Long Haul COVID
Movement Disorders
Multiple Sclerosis (MS)
Neuralgia
Neuromyelitis Optica
Optic Neuritis
Patent Foramen Ovale
Relapsing Multiple Sclerosis (RMS)
Severe Acute Respiratory Syndrome (SARS)
Transverse Myelitis
Whipple Disease
Bruce J. Brew is a male healthcare provider who helps people with various health conditions like AIDS Dementia Complex, HIV/AIDS, Alzheimer's Disease, ALS, Dementia, and many others. He also works with patients who have COVID-19, heart tumors, liver failure, and other serious illnesses.
Bruce J. Brew uses special skills and treatments to care for his patients. He communicates with them in a kind and understanding way, which helps build trust. Patients trust him because he listens to their concerns and explains things clearly.
Bruce J. Brew stays updated with the latest medical knowledge and research to provide the best care possible. He works closely with other medical professionals to share information and collaborate on patient care. His relationships with colleagues are strong, and they work together to improve patient outcomes.
Bruce J. Brew's work has positively impacted many patients' lives. He has published research on topics like the neuropathogenesis of acute HIV and has been involved in clinical trials for treatments like Donanemab for Alzheimer's Disease.
Overall, Bruce J. Brew is a dedicated healthcare provider who uses his expertise to help patients with a wide range of health issues. His commitment to staying informed and working collaboratively with colleagues ensures that patients receive the best possible care. Through his research and clinical trials, he continues to make a positive impact on the lives and health of those he cares for.
Enrollment Status: Active not recruiting
Published: February 27, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
